Iron-deficiency Clinical Trials

8 recruiting

Iron-deficiency Trials at a Glance

9 actively recruiting trials for iron-deficiency are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 4 with 3 trials, with the heaviest enrollment activity in Boston, Calgary, and Guangzhou. Lead sponsors running iron-deficiency studies include Massachusetts General Hospital, Oulu University Hospital, and AHS Cancer Control Alberta.

Browse iron-deficiency trials by phase

Treatments under study

About Iron-deficiency Clinical Trials

Looking for clinical trials for Iron-deficiency? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Iron-deficiency trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Iron-deficiency clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 4

Oral Iron Supplementation on Alternate vs. Consecutive Days for Iron Deficiency Anemia in Pregnancy

PregnancyIron-deficiency Anemia (IDA)
Southern Illinois University120 enrolled1 locationNCT06492512
Recruiting
Phase 4

Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF)

Iron-deficiencyHeart Failure With Preserved Ejection Fraction
Massachusetts General Hospital66 enrolled1 locationNCT04945707
Recruiting
Phase 2

Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants

Iron-deficiencyPrematurity
University of Washington120 enrolled1 locationNCT05340465
Recruiting
Phase 4

Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure

Iron-deficiencyChronic Heart FailureLeft Ventricular Systolic Dysfunction
Raffaele De Caterina60 enrolled1 locationNCT06270498
Recruiting

PEPPI Study: Identification of Women at Risk for Placental Dysfunction

Cardiovascular DiseasesPolycystic Ovary SyndromePre-Eclampsia+4 more
Oulu University Hospital3,000 enrolled1 locationNCT06115122
Recruiting

Non-invasive Detection of Iron Deficiency in Obstetrics

Iron-deficiencyPostpartum DepressionIron Deficiency Anemia of Pregnancy+5 more
Wuerzburg University Hospital500 enrolled1 locationNCT07083492
Recruiting
Phase 3

Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)

Gynecologic CancerAnemiaIron-deficiency
AHS Cancer Control Alberta82 enrolled1 locationNCT05407987
Recruiting

Impact of Iron Deficiency Anemia on Neurobehavioral and Cognitive Development in Children Aged 6 to 24 Months

Iron-Deficiency AnemiaNeurobehavioral ManifestationsGrowth Disorders+1 more
Pingshan District Maternal & Child Healthcare Hospital of Shenzhen1,000 enrolled1 locationNCT06662045
Recruiting
Phase 2

Iron Isomaltide for Iron-deficiency Anemia Patients With Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal CarcinomaAnemiaIron-deficiency
Sun Yat-sen University120 enrolled1 locationNCT05913414